Gboxin
Gboxin is a small molecule inhibitor of mitochondrial oxidative phosphorylation that selectively targets glioblastoma cells by inhibiting F0F1 ATP synthase activity. It has demonstrated antitumor efficacy in both in vitro and in vivo glioblastoma research models.
Product Specifications
CAS Number
2101315-36-8
Product Name Alternative
Inhibitor, Gboxin, F0F1 ATP synthase, F0F1 ATP synthase, MitochondrialMetabolism, Mitochondrial Metabolism, inhibit, ATP Synthase
Field of Research
Cell Biology, Metabolism Research, Pharmacology & Drug Discovery
Purity
95.62% (May vary between batches)
Solubility
DMSO:30 mg/mL (76.34 mM) ; H2O:10 mg/mL (25.45 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.09 mM)
Smiles
[Cl-].CCc1n (CC (=O) O[C@@H]2C[C@H] (C) CC[C@H]2C (C) C) c2ccccc2[n+]1C
Molecular Formula
C22H33ClN2O2
Molecular Weight
392.96
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CBARA1/MICU1 Monoclonal Antibody, APC-Cy7 Conjugated
Lentiviral human SPP1 shRNA (UAS) - Lentiviral human SPP1 shRNA (UAS, iRFP) (25)
